Microbot Medical Inc
MBOT2.571USD
+0.021+0.84%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
89.34MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Microbot Medical Inc Unternehmen
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
Unternehmensinformationen
BörsenkürzelMBOT
Name des UnternehmensMicrobot Medical Inc
IPO-datumMar 25, 1992
CEOMr. Harel Gadot
Anzahl der mitarbeiter21
WertpapierartOrdinary Share
GeschäftsjahresendeMar 25
Addresse175 Derby St Bld 27
StadtHINGHAM
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl02043
Telefon17818753605
Websitehttp://www.microbotmedical.com/
BörsenkürzelMBOT
IPO-datumMar 25, 1992
CEOMr. Harel Gadot
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
5.05%
Geode Capital Management, L.L.C.
0.78%
BlackRock Institutional Trust Company, N.A.
0.58%
MEDX Ventures Group LLC
0.34%
State Street Global Advisors (US)
0.34%
Other
92.91%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
5.05%
Geode Capital Management, L.L.C.
0.78%
BlackRock Institutional Trust Company, N.A.
0.58%
MEDX Ventures Group LLC
0.34%
State Street Global Advisors (US)
0.34%
Other
92.91%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
6.96%
Investment Advisor/Hedge Fund
1.74%
Research Firm
0.36%
Venture Capital
0.36%
Hedge Fund
0.26%
Other
90.31%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
93
3.70M
9.69%
-538.67K
2025Q1
89
2.58M
7.86%
-1.62M
2024Q4
78
1.58M
4.97%
-880.54K
2024Q3
70
1.52M
8.93%
-946.72K
2024Q2
71
1.56M
9.80%
-833.62K
2024Q1
69
2.54M
18.61%
-153.32K
2023Q4
67
2.61M
22.30%
+489.30K
2023Q3
65
2.09M
17.88%
-264.50K
2023Q2
64
2.33M
23.62%
-218.94K
2023Q1
63
2.51M
30.86%
-204.69K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
741.16K
2.04%
+281.62K
+61.28%
Mar 31, 2025
Geode Capital Management, L.L.C.
316.92K
0.87%
+174.26K
+122.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
236.10K
0.65%
+98.73K
+71.87%
Mar 31, 2025
MEDX Ventures Group LLC
136.85K
0.38%
--
--
Apr 15, 2025
State Street Global Advisors (US)
136.67K
0.38%
+110.60K
+424.24%
Mar 31, 2025
DNB Asset Management AS
114.82K
0.32%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
104.18K
0.29%
+74.45K
+250.44%
Mar 31, 2025
Two Sigma Investments, LP
83.02K
0.23%
+72.29K
+673.87%
Mar 31, 2025
Northern Trust Investments, Inc.
71.06K
0.2%
+57.67K
+430.78%
Mar 31, 2025
UBS Financial Services, Inc.
41.13K
0.11%
+40.06K
+3765.23%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Anteil0.02%
Dimensional US Core Equity 1 ETF
Anteil0%
iShares Core S&P Total U.S. Stock Market ETF
Anteil0%
Avantis US Small Cap Equity ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
